Associate Professor Lee Lui Shiong is currently Head of Department, Department of Urology, Sengkang General Hospital, and a visiting senior consultant with National Cancer Centre Singapore.
With a keen in interest in urologic-oncology, he spear-headed the development of a robotic cystectomy and intra-corporeal reconstruction service, alongside an Enhanced Recovery After Surgery programme and oversaw the development of a one-stop multi-disciplinary clinic with NCCS , catered to patients with advanced urological cancers with the intention of providing holistic care supported by evidence based practices.
Beyond the MDT clinic, he maintains a strong interest in multi-visceral resection surgery such as pelvic exenterations and inferior venae-cavae thrombectomy. He also has strong collaborations with the GAP3 Global Consortium in Prostate Cancer Active Surveillance and the Asian Robotic Cystectomy Consortium. He has also held several research grants supporting investigator initiated trials and studies focused on urologic oncology.
He has also led several award winning QI projects involving improving patient safety and clinical outcomes.
For his efforts in pursuing better clinical outcomes through innovation, he was awarded the Singapore Health Quality Service Award 2024 in the Clinician Exemplar Leader category.
As Site Director for the Singhealth Urology Residency Programme in Sengkang General Hospital, he oversees residency training and development and was recognised as an Outstanding Faculty Member in 2022.
He is President of the Singapore Urological Association.
14th August 2025
Time |
Session |
|
09:00
15:00
|
-
Welcome Remarks
-
Welcome Remarks
-
Bladder Cancer Track
-
MDT Discussion: Treating High-Risk BCG Refractory NMIBC in a ECOG2 75-year-old
-
Debate: Bladder Preservation Should Be Considered for All Cases of MIBC
-
Technical Pearls: Node Dissection in Robotic Cystectomy
-
Technical Pearls: Robotic Intra-Corporeal OBS
-
Practice Changing Papers
-
Coffee Break
-
Prostate Cancer Track
-
MDT Discussion: Personalizing Treatment in High Volume CSPC
-
Debate: PIRADS 4/5 Negative Biopsies Should
-
Technical Pearls: Retzius Sparing
-
Technical Pearls: Nerve-Sparing
-
Technical Pearls: Total Extraperitoneal Technique
-
Practice Changing Papers
-
Group Photo
-
Lunch Break
-
Kidney Cancer Track
-
Treating SRM in a 65-Year-Old ECOG 1 with Multiple Previous Operations-Is Minimally Invasive Treatment Feasible?
-
Treating SRM in a 65-Year-Old ECOG 1 with Multiple Previous Operations-Is SBRT the New Kid on the Block?
-
Debate: Should We Only Offer Consolidative Cytoreductive Nephrectomy in Metastatic RCC?
-
Technical Pearls: Wheel-Barrow Techniques
-
Technical Pearls: Renorrhaphy Techniques
-
Practice Changing Papers
-
Closing Remarks
TICC - 1F 101A
|
15th August 2025
Time |
Session |
|
15:30
17:00
|
Prostate Cancer
-
Prostate Cancer
-
Focal Therapy in Asia – Is It Prime Time?
-
Primary Radical Prostatectomy in Low Volume Metastatic Prostate Cancer
-
Risk Stratification and Contemporary Management of Biochemical Recurrence
-
The Strategy to Initiate PSMA-Based Therapies for Advanced Prostate Cancer
-
Discussion
TICC - 2F 201BC
|
17th August 2025
Time |
Session |
|
08:30
10:00
|
-
Impact of Relugolix versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study (European Urology, 2023)
-
SIU Lecture: Role of MISTs in Male LUTS Surgical Management (Will TUR-P/ Laser Prostatectomy be Replaced?)
-
Updates on Molecular Classification and Diagnostics of Upper Urinary Tract Urothelial Carcinoma
-
A Fully Automated Artificial Intelligence System to Assist Pathologists' Diagnosis to Predict Histologically High-Grade Urothelial Carcinoma from Digitized Urine Cytology
-
Recommendations in Laser Use for the Treatment of Upper Tract Urothelial Carcinoma
-
UTUC Treatment — Evidence & Guideline Recommendation
TICC - 3F Banquet Hall
|